Frontiers in Pharmacology (May 2014)

Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis

  • Amanda B Core,
  • Susanna eCanali,
  • Jodie L. Babitt

DOI
https://doi.org/10.3389/fphar.2014.00104
Journal volume & issue
Vol. 5

Abstract

Read online

Mutations in hemojuvelin (HJV) are the most common cause of the juvenile-onset form of the iron overload disorder hereditary hemochromatosis. The discovery that HJV functions as a co-receptor for the bone morphogenetic protein (BMP) family of signaling molecules helped to identify this signaling pathway as a central regulator of the key iron hormone hepcidin in the control of systemic iron homeostasis. This review highlights recent work uncovering the mechanism of action of HJV and the BMP-SMAD signaling pathway in regulating hepcidin expression in the liver, as well as additional studies investigating possible extra-hepatic functions of HJV. This review also explores the interaction between HJV, the BMP-SMAD signaling pathway and other regulators of hepcidin expression in systemic iron balance.

Keywords